
Salesforce (CRM) Stock Forecast & Price Target
Salesforce (CRM) Analyst Ratings
Bulls say
Salesforce is supported by a strengthening core business, with record pipeline, accelerating cRPO growth to 14% in Q2, and customer surveys showing 10 of 13 respondents expecting spending to rise over the next 12-18 months, while seat counts in Sales, Service, and Slack continue to expand. Its AI and data stack also looks increasingly differentiated: Agentforce and Data ARR reached $3.9B, up 210% y/y, premium AI licenses are only about 5% of mix today, and the company is positioning AIforce, Data 360, and Koa to monetize a large agentic opportunity. Financially, Salesforce is still targeting $63B+ in FY30 revenue, has reiterated margin expansion and growing FCF, and its broad pricing flexibility plus trusted enterprise relationships should help convert AI adoption into durable top- and bottom-line growth.
Bears say
Salesforce is exposed to cyclical demand risk because its global scale makes it vulnerable to macro deterioration, and a weaker enterprise spending backdrop could pressure growth across its broad CRM and cloud portfolio. The negative view also reflects execution risk from agentic AI, since this shift could let competitors differentiate more easily and disrupt key areas such as marketing automation and customer service, which are among the most susceptible. In addition, the investment case depends on margin expansion and disciplined capital allocation, but heavier-than-expected investment could reduce margins while the $8b Informatica acquisition and proposed $5.7b BRZE deal raise M&A and capital return risks.
This aggregate rating is based on analysts' research of Salesforce and is not a guaranteed prediction by Public.com or investment advice.
Salesforce (CRM) Analyst Forecast & Price Prediction
Start investing in Salesforce (CRM)
Order type
Buy in
Order amount
Est. shares
0 shares
FAQs About Salesforce (CRM) Forecast
Salesforce (CRM) Analyst Forecast & Price Prediction
Start investing in Salesforce (CRM)
Order type
Buy in
Order amount
Est. shares
0 shares